CCS
MDT icon

Concentric Capital Strategies’s Medtronic MDT Stock Holding History

Concentric Capital Strategies’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,421
Closed -$643K – 380
2026
Q1 		$643K Buy
+7,421
New +$711K 0.05% 195
2024
Q4 		– Sell
-67,725
Closed -$6.1M – 327
2024
Q3 		$6.1M Buy
+67,725
New +$5.7M 0.25% 99
2023
Q4 		– Sell
-14,717
Closed -$1.15M – 289
2023
Q3 		$1.15M Buy
+14,717
New +$1.23M 0.12% 137

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Concentric Capital Strategies's MDT Position: Q2 2026 in Review

Concentric Capital Strategies sold out of Medtronic (MDT) in Q2 2026, closing a stake of 7,421 shares — an estimated $643K sold.

Concentric Capital Strategies first reported a position in MDT in Q3 2023 and held it in 3 quarters. The position peaked at $6.1M in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Concentric Capital Strategies reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 7,421 Medtronic shares in Q2 2026, an estimated $643K.
  • Concentric Capital Strategies first reported a position in Medtronic in Q3 2023 and held it in 3 quarters.
  • Concentric Capital Strategies's Medtronic position peaked at $6.1M in Q3 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.